The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

SPAC eu­reK­ING ac­quires an­oth­er man­u­fac­tur­er

Last year
Deals

DOD taps Val­isure to car­ry out drug qual­i­ty re­views amid gener­ic short­ages, con­cerns

Last year
FDA+

Emer­gent com­mits to lay­offs and C-suite trim­mings, no longer fo­cus­ing on CD­MO ac­tiv­i­ty

Last year
People

Pfiz­er, Gates Foun­da­tion and oth­ers plan to boost pro­duc­tion of con­tra­cep­tive Sayana Press

Last year

Gink­go Bioworks nets sec­ond con­tract with Mer­ck

Last year
Deals

New FDA guid­ance gives man­u­fac­tur­ers lim­its for ni­trosamines

Last year
Pharma
FDA+

BAR­DA or­ders more small­pox and mpox vac­cines from Bavar­i­an Nordic

Last year
Deals
Pharma

Man­u­fac­tur­ing roundup: Mus­tang Bio clos­es sale with uBri­Gene; In­di­an syrup man­u­fac­tur­er halts pro­duc­tion af­ter gov­ern­ment or­der

Last year

In­no­force names De­wan Zeng as the new CEO

Last year
People
China

Re­gen­eron plans for quick re­de­ci­sion on CRL for high­er dose of Eylea

Last year
Pharma
FDA+

Rep­re­sen­ta­tives con­cerned over DSC­SA im­ple­men­ta­tion and sup­ply chain dis­rup­tion

Last year
FDA+

Out­sourc­ing com­pa­ny Ster­Rx to shut New York plant and lay off 161 em­ploy­ees due to ‘eco­nom­ic’ rea­sons

Last year
People

Te­va sees rev­enue in­creas­es in Q2 as it con­tin­ues its ‘piv­ot to growth’ dri­ve

Last year
Pharma

Com­mon can­cer drug man­u­fac­tur­er warned by the FDA over da­ta in In­dia

Last year
Pharma
FDA+

FDA and DEA call on AD­HD drug man­u­fac­tur­ers to up pro­duc­tion amid on­go­ing short­ages

Last year
FDA+

BAR­DA awards Emer­gent 10-year, $704M con­tract for Ebo­la treat­ment

Last year
Deals

Bio­Marin touts Vox­zo­go sales bump in Q2 re­sults, notes 'tem­porar­i­ly tight sup­ply'

Last year
Pharma

FDA looks to work with more out­side agen­cies for in­spec­tions as it en­ters in­to an agree­ment for in­spec­tions with Switzer­land

Last year
Pharma
FDA+

US gov­ern­ment to ac­quire $138M worth of Tpoxx dos­es

Last year
Pharma

Man­u­fac­tur­ing roundup: Cu­ria se­cures deal with Touch­light; Gene-fo­cused Vec­tor­Builder hits ‘uni­corn sta­tus’

Last year

Ako­rn’s bank­rupt­cy, re­calls bring a drug to treat lead poi­son­ing in­to short­age

Last year
R&D

As pres­sure mounts to take ac­tion on drug short­ages, law­mak­ers seek to boost pro­duc­tion in the US

Last year
Pharma
FDA+

An­oth­er dosage of Eli Lil­ly’s Moun­jaro is in short­age

Last year
Pharma

Ther­mo Fish­er's rev­enue falls in Q2 amid 'chal­leng­ing' cli­mate for biotechs and in Chi­na

Last year
Pharma
First page Previous page 26272829303132 Next page Last page
A service from the Financial Times